Received Mar 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
no smell; no taste; I am feeling depressed; lost weight; This non-serious case was reported by a consumer and described the occurrence of anosmia in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included anosmia (4 months of no smell). On 07-NOV-2024, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced anosmia (Verbatim: no smell), taste absent (Verbatim: no taste), depressed mood (Verbatim: I am feeling depressed) and weight loss (Verbatim: lost weight). The outcome of the anosmia and taste absent were not resolved and the outcome of the depressed mood and weight loss were not reported. It was unknown if the reporter considered the anosmia, taste absent, depressed mood and weight loss to be related to Shingrix. It was unknown if the company considered the anosmia, taste absent, depressed mood and weight loss to be related to Shingrix. Additional Information: GSK receipt date: 04-MAR-2025 The patient reported that she had recived Shingrix vaccine and experienced 4 months of no smell, no taste. Also, she was feeling depressed and had lost weight.
Anosmia (4 months of no smell)